Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Radiotherapy & Radiosurgery
Radiation therapy for ovarian cancer
Radiation therapy for ovarian cancer is primarily used to treat recurrent, localised disease or to relieve pain and symptoms in advanced stages. Learn how targeted techniques like IMRT and stereotactic radiotherapy work, what scientific evidence says, approximate costs across Turkey, the UK, US and Germany, what to expect during daily sessions, recovery milestones, side effects, and how to evaluate oncology centres.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Radiotherapy & Radiosurgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Radiation Therapy for Ovarian Cancer
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Radiation therapy for ovarian cancer in Turkey: what it is and how it works
Radiation therapy for ovarian cancer uses targeted, high-energy X-ray beams to damage cancer cell DNA, preventing cells from multiplying. Unlike cervical or uterine cancers where radiotherapy is a routine primary therapy, ovarian cancer is rarely treated with radiation at initial diagnosis. Epithelial ovarian tumours usually spread microscopically across the peritoneal cavity, making surgical debulking and systemic chemotherapy the standard first-line treatments. However, modern radiotherapy is an important, targeted option for specific clinical presentations, particularly for isolated recurrent tumours, oligometastatic lymph nodes, and symptom relief.
What is radiation therapy for ovarian cancer used for today? Clinicians mainly recommend it when cancer recurs in one or a few isolated areas (oligorecurrence) after chemotherapy, or to relieve localized pain or bleeding. Modern linear accelerators shape beams down to millimetres, delivering high doses to tumours while sparing adjacent bowel and bladder tissue. Hospitals providing oncology treatments in Turkey offer advanced radiation modalities as part of multidisciplinary care. The radiation therapy for ovarian cancer in Turkey is often considered by international patients seeking advanced linear accelerator technology.
Does radiation therapy for ovarian cancer work?
Yes, for specific indications. When asking does radiation therapy for ovarian cancer work, the answer depends on the distribution of disease. Decades ago, whole-abdominal radiation treated the entire peritoneal cavity with broad fields, causing severe bowel toxicity. That approach was abandoned in favour of modern chemotherapy. Today, targeted external beam radiotherapy treats only visible, discrete tumour deposits.
Clinical evidence confirms that modern techniques such as Stereotactic Body Radiotherapy (SBRT) achieve local tumour control rates between 80% and 95% at one to two years for isolated nodal or soft-tissue recurrences. This provides a valuable alternative for platinum-resistant recurrence when further chemotherapy is ineffective or repeat surgery is too risky. However, radiation does not cure widespread peritoneal carcinomatosis where hundreds of tiny tumour seedlings coat the abdomen; systemic therapies remain essential. A reputable team will explain that radiotherapy is a targeted local treatment, not a whole-body cure.
Radiation therapy for ovarian cancer cost in Turkey compared with the UK, US and Germany
The figures below show approximate cost ranges for a complete course of radiotherapy, not individual hospital quotes. Pricing depends on whether you receive short-course stereotactic radiation (three to five sessions) or extended conventional radiotherapy (twenty to twenty-eight sessions), required planning scans, and medical oncology reviews.
| Country | Approximate cost range |
|---|---|
| Turkey | €3,000 – €9,000 |
| United Kingdom | €8,500 – €22,000 |
| United States | €18,000 – €55,000 |
| Germany | €7,500 – €20,000 |
What influences the radiation therapy for ovarian cancer cost: the radiation technique chosen, the number of daily fractions, computerised dosimetric planning, and pre-treatment imaging (such as 4D-CT or PET-CT). Packages in Turkey typically include consultations, simulation scanning, medical physics contouring, linear accelerator sessions, nursing support, and local transfers. To confirm the radiation therapy for ovarian cancer price for your situation, request an itemised plan through our free quote page before travelling.
SBRT, IMRT or brachytherapy: which technique is used?
Modern radiotherapy uses several distinct delivery methods depending on tumour size, location, and proximity to sensitive organs.
| Technique | Best suited to | Typical limits |
|---|---|---|
| SBRT / SABR | Isolated recurrent tumours and lymph nodes (1–3 lesions) | Unsuitable for diffuse peritoneal spread; strict size limits |
| IMRT / VMAT | Larger pelvic nodal regions or recurrent masses near sensitive organs | Requires daily sessions over 3–5 weeks; delivers low low-dose bath |
| Brachytherapy | Vaginal cuff or localized central pelvic recurrences | Invasive applicator placement; very limited penetration depth |
Stereotactic Body Radiotherapy (SBRT), or Stereotactic Ablative Radiotherapy (SABR), delivers intense, focused doses in three to five sessions with sub-millimetre precision. Intensity-Modulated Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) vary beam intensity dynamically as the machine rotates, moulding doses around curved pelvic anatomy. Advanced platforms such as tomotherapy integrate helical CT imaging with beam delivery to adjust for bowel motion. In contrast, specialised systems like the gamma knife treat brain metastases exclusively and are not used for pelvic or abdominal tumours.
Who is a candidate for ovarian cancer radiotherapy, and who is not?
Radiation therapy suits specific clinical scenarios rather than every stage of ovarian cancer. An oncology team reviews imaging, pathology, and treatment history to confirm eligibility.
Good candidates typically include:
- Patients with oligorecurrent disease showing one to three distinct lesions on PET-CT or MRI.
- Isolated pelvic, para-aortic, or retroperitoneal lymph node recurrences that cannot be safely operated on.
- Focal tumours causing distressing symptoms such as pelvic pain, bleeding, or urinary obstruction.
- Platinum-resistant disease where focused radiation delays further disease progression.
- Patients able to travel and lie still on the treatment couch for 15 to 30 minutes.
Patients who are not suitable candidates include:
- Those with widespread peritoneal carcinomatosis dispersed across the abdomen.
- Patients who received prior full-dose radiation to the exact same anatomical region.
- Cases where bowel loops are tightly adherent to the recurrent mass, posing severe perforation risks.
The radiotherapy process step by step: simulation to treatment
Radiotherapy involves precise clinical preparation to target tumours and protect healthy tissue:
1. Consultation and scan review: The radiation oncologist reviews your recent PET-CT or MRI scans, pathology, and surgical history to confirm target areas and clinical goals.
2. Simulation and immobilisation: You attend a simulation session where the team moulds a custom vacuum cushion to support your pelvis and legs, ensuring an identical position every day. A planning CT scan is performed in this position with specific bladder-filling instructions and contrast to outline bowel loops.
3. Dosimetry planning: Over two to four days, medical physicists and your radiation oncologist contour the tumour and surrounding organs at risk (bowel, bladder, rectum). Specialised software calculates optimal beam angles and safe dose distributions.
4. Daily treatment delivery: You lie on the linear accelerator couch in your mould. On-board cone-beam CT checks your alignment within millimetres. The machine rotates silently, delivering radiation in 10 to 20 minutes. The beam involves no physical sensation, no anaesthesia is needed, and you return to your hotel immediately afterward.
Before and after radiotherapy: what results are realistic?
Unlike surgery where tissue removal is immediate, radiation results develop gradually. Ionizing radiation damages cancer cell DNA, causing cells to die as they attempt to divide. Tumour shrinkage typically occurs over eight to twelve weeks after completing therapy.
Realistic results are confirmed on medical imaging rather than physical appearance. A contrast CT or PET-CT scan performed two to three months after treatment shows whether the treated tumour has shrunk, stabilised, or resolved. Blood tests measuring CA-125 often reflect this response with lower values. For isolated recurrences treated with SBRT, local control rates are high, meaning the targeted lesion stops growing in most patients. However, radiation does not prevent new tumours from developing in other untreated parts of the abdomen, making ongoing monitoring with your primary oncologist essential.
Your trip to Turkey and recovery step by step
For stereotactic body radiotherapy (SBRT), consisting of three to five alternate-day sessions, most patients stay in Turkey for 10 to 14 days. This covers consultation, simulation, computer planning, and all fractions. Conventional radiotherapy of 20 to 25 daily fractions requires four to five weeks. When organising radiation therapy for ovarian cancer Turkey clinics provide dedicated coordinators for appointments and transfers.
During radiation therapy for ovarian cancer recovery, milestones follow a predictable timeline:
- During treatment: Sessions do not cause acute nausea or hair loss. You can walk and eat normally. Mild fatigue or loose stools may appear during the second half of treatment.
- Weeks 1 to 4: Pelvic inflammation peaks around a week after your last fraction and resolves over the next three weeks. Drink fluids, rest, and follow a low-residue diet if bowel habits change. Energy returns steadily.
- Months 2 to 3: Irradiated tumour cells continue breaking down. Your first follow-up imaging and CA-125 test take place eight to twelve weeks post-treatment to assess tumour response.
Risks and potential side effects of pelvic radiotherapy
Every cancer treatment carries risks. Professional bodies including the National Health Service (NHS), the American Society for Radiation Oncology (ASTRO), and Macmillan Cancer Support divide radiotherapy side effects into acute, short-term reactions and late complications.
Acute side effects occur during treatment and usually resolve within four to six weeks:
- Fatigue: Temporary tiredness as the body repairs normal cells.
- Bowel irritation: Mild diarrhoea, cramping, or radiation enteritis, managed with dietary adjustments and medication.
- Bladder irritation: Mild urinary urgency or discomfort (radiation cystitis).
- Skin changes: Mild warmth or redness in the treated area, though modern beams keep skin doses minimal.
Late side effects are less common but may arise months or years later. These include chronic bowel changes, pelvic tissue fibrosis, vaginal dryness if the vaginal cuff was irradiated, and leg lymphedema if extensive pelvic lymph nodes were treated. Severe complications like bowel stricture or fistulae are rare. Sharing your complete surgical and radiation history helps the team keep cumulative doses safely within normal tissue limits.
How to choose an oncology centre, red flags and questions to ask
When selecting a hospital for radiotherapy abroad, verify that it holds international accreditation (such as JCI) and uses modern linear accelerators with on-board cone-beam CT guidance. Treatment plans should always be reviewed by a multidisciplinary tumour board including radiation oncologists, medical oncologists, and gynaecological surgeons. Read how our process works to see how medical records and scans are evaluated before travel. Red flags include claims of assured cancer cure, pressure to start without reviewing recent scans, or clinics with no named radiation oncologist. Request an assessment through our free quote service.
Key questions to ask your oncology team:
- Which radiation technique (SBRT, IMRT, or VMAT) do you recommend for my recurrence, and why?
- How will margins and computer planning protect my bowel and bladder?
- How many sessions do I need, and how many days must I stay in Turkey?
- What daily imaging verifies beam positioning on the treatment table?
- What medications do you provide if I develop bowel or bladder symptoms?
- When should I schedule my first follow-up PET-CT scan after returning home?
Conditions treated with Radiation Therapy for Ovarian Cancer
Hospitals with Oncology in Turkey
Frequently asked questions
Radiation therapy for ovarian cancer uses targeted high-energy X-ray beams to damage cancer cell DNA in localized areas. While systemic chemotherapy and surgery remain the primary frontline treatments for ovarian cancer, modern radiotherapy is frequently applied to treat focal recurrences, oligometastatic lymph nodes, or to alleviate pain and bleeding in advanced stages.
Yes, clinical evidence confirms that modern techniques like stereotactic body radiotherapy achieve local control rates of 80% to 95% for isolated recurrent tumours or lymph node deposits. However, it is not an effective treatment for widespread peritoneal carcinomatosis, where systemic chemotherapy and targeted biological drugs remain essential.
In Turkey, the cost of radiation therapy for ovarian cancer typically ranges from €3,000 to €9,000. In comparison, equivalent treatments in the UK range from €8,500 to €22,000, and up to €55,000 in the US. Final prices depend on whether treatment involves short-course stereotactic radiation or several weeks of daily fractions.
Before treatment, you undergo a simulation CT scan and customized immobilisation fitting to plan millimeter-accurate beam targeting. After completing the course, acute fatigue and bowel inflammation gradually resolve over two to four weeks. Restaging scans at eight to twelve weeks assess tumour regression, stability, and reduction in cancer markers such as CA-125.
Most patients experience immediate recovery within two to four weeks following their final session, as temporary fatigue, bowel irritation, and urinary urgency subside. Long-term tissue healing and complete tumour response are evaluated over three to six months. Gentle daily walks are encouraged throughout treatment, with normal non-strenuous routines resuming quickly.
The delivery of radiation therapy involves no physical sensation during the session, feeling similar to a diagnostic X-ray. You lie still while the linear accelerator rotates around you. Minor discomfort, such as abdominal cramping, skin warmth, or mild bladder irritation, can develop midway through therapy and is managed with supportive medication.
Radiation-induced DNA damage halts the reproductive cycle of irradiated tumour cells, leading to cell death and tumour shrinkage. In localized recurrences treated with ablative stereotactic radiation, local disease control often lasts for years, though patients continue regular oncological surveillance to monitor for potential distant disease elsewhere in the body.
Modern radiation therapy is safe when planned with advanced technologies like intensity modulation and daily image guidance. These tools shape beams tightly around tumour targets while shielding the sensitive small bowel, rectum, and kidneys. Potential side effects are carefully monitored by the oncology team and discussed before starting treatment.
Stereotactic body radiotherapy delivers concentrated radiation doses in three to five sessions with millimeter precision, making it suitable for small, isolated recurrent tumours. Conventional external beam radiotherapy distributes smaller daily fractions over three to five weeks, which is preferred when treating larger pelvic fields, extensive nodal chains, or broader anatomical areas.
For stereotactic body radiotherapy involving three to five fractions, patients typically stay in Turkey for 10 to 14 days to allow for initial consultations, simulation imaging, computerized dosimetry planning, and treatment delivery. For extended conventional radiotherapy protocols requiring several weeks of daily fractions, stays of four to six weeks are necessary.
Patient stories